The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

NCT03188276 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Ledipasvir-Sofosbuvir
DRUG: Daclatasvir-Sofosbuvir

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University